Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Indivior Pharmaceuticals Inc
NASDAQ:INDVHealthcare · Drug Manufacturers - Specialty & Generic
+0.34%$35.37
AH$36.00+1.78%vs close
Mkt Cap$4.17B
Float116.56M
O/S118.04M
Vol
$ Vol
RVOL
Inst Own-
SI8.1%
Earnings
Dilution
Financials Summary
Revenue$1.24B
Net Income$210M
Total Assets$1.2B
Free Cash Flow-$94M
Debt & Equity
Debt 139%
Total Debt$351M
Total Equity-$98M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in INDV's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.2B
Liabilities$1.3B
Accounts Receivable$255M
Accounts Payable$48M
Inventory$153M
PP&E (Net)$170M
Goodwill$0
Intangible Assets$2M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $1.24B | $1.19B | $1.09B | $901M | $791M | $647M | $785M | $959.92M | $1.15B | $968.89M |
| YoY Growth | 4.3% | 8.7% | 21.3% | 13.9% | 22.3% | -17.6% | -18.2% | -16.4% | 18.5% | - |
| Cost of Revenue | $246M | $231M | $174M | $151M | $127M | $97M | $140M | $134.68M | $122.9M | $110.81M |
| Gross Profit | $993M | $957M | $919M | $750M | $664M | $550M | $645M | $825.25M | $1.03B | $858.08M |
| Gross Margin | 80.1% | 80.6% | 84.1% | 83.2% | 83.9% | 85.0% | 82.2% | 86.0% | 89.3% | 88.6% |
| Research and Development | $97M | $107M | $116M | $74M | $52M | $40M | $53M | $63.99M | $93.49M | $108.98M |
| Selling, General, and Administrative | $634M | $618M | $569M | $469M | $431M | $649M | $395M | $444.14M | $508.4M | $411.18M |
| Other | -$3M | $200M | $390M | $288M | -$32M | $17M | $19M | $0 | $0 | $0 |
| Total Operating Expenses | $728M | $925M | $1.07B | $831M | $451M | $706M | $467M | $508.14M | $601.89M | $520.16M |
| Operating Income (EBIT) | $265M | $32M | -$156M | -$81M | $213M | -$156M | $178M | $317.11M | $423.32M | $337.92M |
| Operating Margin | 21.4% | 2.7% | -14.3% | -9.0% | 26.9% | -24.1% | 22.7% | 33.0% | 36.9% | 34.9% |
| Interest Expense | $45M | $41M | $35M | $29M | $26M | $24M | $22M | $31M | $49M | $51M |
| Interest Income | $22M | $23M | $43M | $19M | $4M | $7M | $24M | $17M | $7M | $0 |
| Other Income (Expense) | -$26M | -$18M | $7M | -$8M | -$23M | -$17M | $2M | -$14M | -$56M | -$51M |
| Income Before Tax (EBT) | $239M | $14M | -$149M | -$89M | $190M | -$173M | $180M | $265.53M | $143.91M | $89.75M |
| Income Tax Expense | $29M | $11M | -$20M | -$44M | -$15M | -$25M | $46M | $2.87M | $82.98M | $57.69M |
| Net Income | $210M | $2M | -$129M | -$44M | $205M | -$148M | $134M | $262.67M | $60.92M | $32.05M |
| Net Income Margin | 16.9% | 0.2% | -11.8% | -4.9% | 25.9% | -22.9% | 17.1% | 27.4% | 5.3% | 3.3% |
| Supplementary Data | ||||||||||
| EPS | 1.68 | 0.02 | -0.94 | -0.37 | 1.38 | -1.08 | 0.95 | 1.81 | 0.42 | 0.22 |
| Diluted EPS | 1.64 | 0.01 | -0.91 | -0.37 | 1.31 | -1.08 | 0.92 | 1.75 | 0.41 | 0.22 |
| Weighted Average OS | 125.00M | 132.00M | 137.31M | 139.01M | 145.66M | 146.57M | 146.05M | 145.43M | 144.23M | 143.97M |
| EBITDA | $304M | $83M | -$99M | -$46M | $238M | -$123M | $230M | $311.14M | $206M | $150.45M |
| EBITDA Margin | 24.5% | 7.0% | -9.1% | -5.1% | 30.1% | -19.0% | 29.3% | 32.4% | 17.9% | 15.5% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $195M | $319M | $316M | $778.18M | $1.1B | $858M | $1.06B | $924M | $863M | $692M |
| Short-Term Investments | $0 | $1M | $94M | $119.64M | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $195M | $320M | $410M | $897.83M | $1.1B | $858M | $1.06B | $924M | $863M | $692M |
| Accounts Receivable | $255M | $254M | $254M | $220M | $202M | $219M | $204M | $278M | $257M | $205M |
| Inventory | $153M | $178M | $135M | $114.62M | $95M | $93M | $73M | $78M | $52M | $41M |
| Other Current Assets | $15M | $34M | $444M | $18M | $27M | $0 | $0 | $49M | $38M | $40M |
| Total Current Assets | $652M | $839M | $1.27B | $1.27B | $1.44B | $1.19B | $1.36B | $1.33B | $1.22B | $990M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $170M | $139M | $124M | $85.46M | $95M | $103M | $107M | $57M | $54M | $27M |
| Goodwill | $0 | $2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $2M | $5M | $13M | $70M | $82M | $62M | $72M | $0 | $0 | $0 |
| Long-Term Investments | $28M | $26M | $41M | $98.53M | $0 | $0 | $0 | $33M | $15M | $0 |
| Deferred Tax Assets | $326M | $280M | $293M | $220.18M | $105M | $75M | $40M | $44M | $58M | $109M |
| Other Long-Term Assets | $26M | $29M | $28M | $38.58M | $106M | $104M | $73M | $84M | $92M | $83M |
| Total Long-Term Assets | $552M | $481M | $499M | $512.76M | $388M | $344M | $292M | $218M | $219M | $219M |
| Other Assets | $0 | -$1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.2B | $1.32B | $1.76B | $1.78B | $1.83B | $1.53B | $1.65B | $1.55B | $1.44B | $1.21B |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $48M | $63M | $39M | $33M | $26M | $416M | $499M | $47M | $40M | $33M |
| Short-Term Debt | $39M | $18M | $12M | $3M | $3M | $12M | $9M | $4M | $5M | $101M |
| Current Income Tax Payable | $2M | $46M | $17.97M | $9.05M | $18M | $15M | $39M | $24M | $41M | $52M |
| Current Unearned Revenue | $0 | $0 | $0 | $9.05M | $0 | $0 | $0 | $24M | $41M | $52M |
| Other Current Liabilities | $722M | $802M | $1.16B | $391M | $635M | $156M | $195M | $603M | $617M | $673M |
| Total Current Liabilities | $914M | $939M | $1.29B | $1.02B | $804M | $599M | $742M | $818M | $854M | $1.03B |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $290M | $315M | $237M | $237M | $239M | $230M | $233M | $237M | $477M | $434M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $3M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $73M | $381M | $390M | $436.78M | $550M | $577M | $417M | $426M | $316M | $40M |
| Total Long-Term Liabilities | $388M | $728M | $666M | $702.78M | $825M | $850M | $701M | $663M | $793M | $474M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.3B | $1.67B | $1.96B | $1.73B | $1.63B | $1.45B | $1.44B | $1.48B | $1.65B | $1.5B |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $62M | $62M | $68M | $68.37M | $70M | $73M | $73M | $73M | $72M | $72M |
| Retained Earnings | -$243M | -$454M | -$295M | $1.31B | $1.44B | $1.31B | $1.45B | $1.31B | $1.03B | $950M |
| Comprehensive Income & Other | -$30M | -$46M | -$1.35B | -$1.34B | $0 | -$1.31B | -$1.32B | -$1.33B | -$1.31B | -$1.32B |
| Other Stockholders' Equity | $83M | $44M | $36M | -$1.33B | -$1.3B | -$1.3B | -$1.31B | -$1.32B | -$1.31B | -$1.32B |
| Total Equity | -$98M | -$348M | -$191M | $51.28M | $203M | $82M | $209M | $66M | -$203M | -$295M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.2B | $1.32B | $1.76B | $1.78B | $1.83B | $1.53B | $1.65B | $1.55B | $1.44B | $1.21B |
| Supplementary Data | ||||||||||
| Total Debt | $351M | $375M | $283M | $277M | $286M | $285M | $293M | $241M | $482M | $535M |
| Net Debt | $156M | $56M | -$33M | -$501.18M | -$816M | -$573M | -$767M | -$683M | -$381M | -$157M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | $210M | $7M | -$126M | -$44M | $213M | -$156M | $178M | $292M | $193M | $149M |
| Depreciation & Amortization | $20M | $28M | $15M | $16M | $22M | $26M | $28M | $16M | $13M | $14M |
| Deferred Income Tax | -$46M | $7M | -$64M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $26M | $24M | $21M | $16M | $11M | $8M | $3M | $15M | $16M | $10M |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | $3M | -$1M | -$33M | -$21M | -$25M | $15M | $79M | -$33M | -$59M | -$27M |
| Inventory | $18M | -$43M | -$6M | -$30M | -$3M | -$16M | $7M | -$31M | -$6M | $4M |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | -$278M | -$2M | -$258M | $169M | $201M | -$18M | -$165M | $93M | $206M | $361M |
| Total Working Capital Change | -$257M | -$46M | -$297M | $118M | $173M | -$19M | -$79M | $29M | $141M | $338M |
| Other Non-Cash Items | $20M | $16M | $151M | -$110M | -$66M | -$52M | $21M | -$49M | -$68M | -$104M |
| Net Cash from Operating | -$27M | $36M | -$300M | -$4M | $353M | -$193M | $151M | $303M | $295M | $407M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$66M | -$29M | -$8M | -$5M | -$4M | -$4M | -$7M | -$11M | -$30M | -$20M |
| Acquisitions | $0 | $0 | -$129M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$20M | -$17M | -$45M | -$245M | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $20M | $117M | $129M | $27M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$2M | -$42M | $1M | -$10M | $0 | $5M | $7M | -$13M | -$15M |
| Net Cash from Investing | -$66M | $69M | -$95M | -$222M | -$14M | -$4M | -$2M | -$4M | -$43M | -$35M |
| Financing Activities | ||||||||||
| Debt Repaid | $17M | -$92M | $12M | $3M | -$14M | $4M | $4M | $240M | $86M | $78M |
| Common Stock Issuance | -$3M | -$19M | -$19M | -$8M | $1M | $1M | $0 | $3M | $2M | $0 |
| Common Stock Repurchases | -$11M | -$173M | -$33M | -$90M | -$101M | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$69M |
| Other Financing Activities | $1M | -$2M | $0 | $0 | -$8M | -$7M | -$9M | $0 | $0 | $0 |
| Net Cash from Financing | -$30M | -$102M | -$64M | -$101M | -$94M | -$10M | -$13M | -$237M | -$84M | -$147M |
| Forex Effect | -$1M | $0 | $1M | -$1M | -$1M | $5M | $0 | -$1M | $3M | $0 |
| Net Change in Cash | -$124M | $3M | -$458M | -$328M | $244M | -$202M | $136M | $61M | $171M | $225M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$27M | $36M | -$300M | -$4M | $353M | -$193M | $151M | $303M | $295M | $407M |
| Capital Expenditure | -$67M | -$31M | -$53M | -$5M | -$34M | -$4M | -$7M | -$41M | -$43M | -$35M |
| Free Cash Flow | -$94M | $5M | -$353M | -$9M | $319M | -$197M | $144M | $262M | $252M | $372M |
| Cash at Beginning | $319M | $316M | $774M | $1.1B | $858M | $1.06B | $924M | $863M | $692M | $467M |
| Cash at End | $195M | $319M | $316M | $774M | $1.1B | $858M | $1.06B | $924M | $863M | $692M |